Skip to content
Search

Latest Stories

Top Stories

28 miles to the nearest pharmacy? For many, that's the only option.

Closed pharmacy

Pharmacies are closing all across the United States.

J. Michael Jones/Getty Images

Pharmacies in the United States are closing at an alarming rate. The ACT Pharmacy Collaborative, a partnership between community pharmacy networks and academia, reported that 244 pharmacies closed in just the first six weeks of 2024. Similarly, Rite-Aid has closed 500 stores, CVS will close another 300 stores by the end of the year and Walgreens will close 1,200 over the next three years.

In my home state of Oregon, pharmacists are constantly facing untenable scenarios. At a recent hearing, a pharmacist from a rural community testified how a woman from a neighboring town called his pharmacy late in the day needing to urgently fill a prescription. Unfortunately, the only pharmacy in her town had permanently closed, so she was stuck frantically attempting to locate someone who took their insurance and had the medication in stock. His pharmacy had the medication, so while she drove 28 miles on rural roads, the pharmacy stayed open — 30 minutes after closing because that’s what pharmacists do. We take care of patients.


Afterwards, when the patient had the medication in hand and was counseled on how to use it correctly, the pharmacist checked to see how much was made from the prescription. To his dismay, in the end, the pharmacy was reimbursed $23 below the drug’s acquisition price. His pharmacy lost money for taking care of a patient that evening.

Now it might be easy to chalk this up as an isolated incident — an unfortunate anomaly or glitch in our health care system. However, instances like this happen on a regular basis and it has become commonplace to have a prescription reimbursed at an amount that is less than the cost to acquire and dispense the drug. Given the high cost of medications, this may come as a surprise. However, pharmacy benefit managers currently have an outsized influence on the financial health of many community pharmacies.

PBMs are middlemen — often invisible to the patient — that are located at the interface of drug manufacturers, payers and their employer-sponsors, and community pharmacies. They began over 50 years ago as a solution to help payers manage the complexity of prescription drug benefits. PBMs were highly efficient at claims processing, and they do play a role in helping payers process a high volume of relatively small claims. However, over time, the role of PBMs has evolved and expanded to where PBMs are now engaged in negotiating drug prices and determining which medications are covered by a plan’s formulary. They also operate their own pharmacies through closely affiliated partners. This gives PBMs considerable influence on how much pharmacies are paid, which drugs are covered and where patients can fill their prescriptions.

Simultaneously, over time, the PBM market has become highly concentrated. A report released by the Federal Trade Commission in July found that in 2023 the three largest PBMs companies processed approximately 80 percent of the prescriptions dispensed by U.S. pharmacies and that percentage rises to 90 percent if expanding to the six largest PBMs. All the major players are now vertically integrated with other parts of the health sector, often resulting in massive conglomerates where PBMs simultaneously play the role of plan, pharmacy and middleman. The FTC report highlights how PBMs impose “confusing, unfair, arbitrary, and harmful” contractual terms that influence the financial health of pharmacies.

PBMs have grown in such a way that it makes it nearly impossible for the average consumer — or even seasoned policy maker — to understand the problems and propose solutions. And when things are confusing, it is easy to become paralyzed and do nothing. However, in this case, doing nothing is simply not an option. Pharmacies are in crisis. The pharmacy from above has since closed, leaving another rural Oregon town with one less access point for patients.

Momentum for federal regulation that will bring more transparency and accountability to how PBMs influence the drug supply chain has built over the last few years. Multiple bills have come out of congressional committees with unanimous bipartisan support. The chairman of the Senate Finance Committee, Sen. Ron Wyden (D-Ore.), and high-ranking Republicans have expressed support for PBM reform. Congress has now returned to Washington, creating a final and crucial opportunity to pass PBM reform in 2024. It must be done.

To be sure, as a pharmacist, I care deeply about my profession. However, I care even more deeply about the patients that my profession serves. It saddens me that if PBM reform does not pass, then many more pharmacies will close, and more communities will lose pharmacy access. It saddens me that people residing in those communities might need to hold their breath, cross their fingers and hope they are not the patient needing a pharmacy to stay open past close as they drive those 28 miles.

Irwin is a clinical associate professor at Oregon State University’s College of Pharmacy and a public voices fellow with The OpEd Project. She is also a former president of the Oregon State Pharmacy Association.

Read More

Just the Facts: Impact of the Big Beautiful Bill on Health Care

U.S. President Donald Trump takes the stage during a reception for Republican members of the House of Representatives in the East Room of the White House on July 22, 2025 in Washington, DC. Trump thanked GOP lawmakers for passing the One Big Beautiful Bill Act.

Getty Images, Chip Somodevilla

Just the Facts: Impact of the Big Beautiful Bill on Health Care

The Fulcrum strives to approach news stories with an open mind and skepticism, striving to present our readers with a broad spectrum of viewpoints through diligent research and critical thinking. As best we can, we remove personal bias from our reporting and seek a variety of perspectives in both our news gathering and selection of opinion pieces. However, before our readers can analyze varying viewpoints, they must have the facts.

What are the new Medicaid work requirements, and are they more lenient or more restrictive than what previously existed?

Keep ReadingShow less
U.S. Constitution
Imagining constitutions
Douglas Sacha/Getty Images

A Bold Civic Renaissance for America’s 250th

Every September 17, Americans mark Constitution Day—the anniversary of the signing of our nation’s foundational charter in 1787. The day is often commemorated with classroom lessons and speaking events, but it is more than a ceremonial anniversary. It is an invitation to ask: What does it mean to live under a constitution that was designed as a charge for each generation to study, debate, and uphold its principles? This year, as we look toward the semiquincentennial of our nation in 2026, the question feels especially urgent.

The decade between 1776 and 1787 was defined by a period of bold and intentional nation and national identity building. In that time, the United States declared independence, crafted its first national government, won a war to make their independence a reality, threw out the first government when it failed, and forged a new federal government to lead the nation. We stand at a similar inflection point. The coming decade, from the nation’s semiquincentennial in 2026 to the Constitution’s in 2037, offers a parallel opportunity to reimagine and reinvigorate our American civic culture. Amid the challenges we face today, there’s an opportunity to study, reflect, and prepare to write the next chapters in our American story—it is as much about the past 250 years, as it is about the next 250 years. It will require the same kind of audacious commitment to building for the future that was present at the nation’s outset.

Keep ReadingShow less
Texas redistricting maps

Two bills have been introduced to Congress that aim to ban mid-decade redistricting on the federal level and contain provisions making an exception for mid-decade redistricting.

Tamir Kalifa/Getty Images

Congress Bill Spotlight: Anti-Rigging Act, Banning Mid-Decade Redistricting As Texas and California Are Attempting

Trump claims Republicans are “entitled” to five more Texas House seats.

Context: in the news

In August, the Republican-controlled Texas state legislature approved a rare “mid-decade” redistricting for U.S. House seats, with President Donald Trump’s encouragement.

Keep ReadingShow less
Independent Madness- or How the Cheshire Cat Can Slay the Gerrymander

The Cheshire Cat (John Tenniel) Devouring the Gerrymander (Elkanah Tisdale )

Independent Madness- or How the Cheshire Cat Can Slay the Gerrymander

America has a long, if erratic, history of expanding its democratic franchise. Over the last two centuries, “representation” grew to embrace former slaves, women, and eighteen-year-olds, while barriers to voting like literacy tests and outright intimidation declined. Except, that is, for one key group, Independents and Third-party voters- half the electorate- who still struggle to gain ballot access and exercise their authentic democratic voice.

Let’s be realistic: most third parties aren't deluding themselves about winning a single-member election, even if they had equal ballot access. “Independents” – that sprawling, 40-percent-strong coalition of diverse policy positions, people, and gripes – are too diffuse to coalesce around a single candidate. So gerrymanderers assume they will reluctantly vote for one of the two main parties. Relegating Independents to mere footnotes in the general election outcome, since they’re also systematically shut out of party primaries, where 9 out of 10 elections are determined.

Keep ReadingShow less